FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matthew During

Research Profile

Living Beings

Chemicals & Drugs

Procedures

Genetic Therapy

Anatomy

Physiology

Devices

Gene Transfer Techniques

Activities & Behaviors

Animal Behavior

Co-author Network

Publications

TOP 3
Katherine H Carruthers; Matthew J During; Alexander Muravlev; Chuansong Wang; Ergun Kocak
Fat grafting as a vehicle for the delivery of recombinant adenoassociated viral vectors to achieve gene modification of muscle flaps.
Peter Charbel Issa; Samantha R De Silva; Matthew J During; Mark W Hankins; Daniel M Lipinski; Alexandre Mouravlev; Mandeep S Singh; Qisheng You; Alun R Barnard; Robert E Maclaren
Assessment of Tropism and Effectiveness of New Primate-Derived Hybrid Recombinant AAV Serotypes in the Mouse and Primate Retina.
Paola Leone; S W J McPhee; R Jude Samulski; David Shera; Dah-Jyuu Wang; Deborah Young; Edwin H Kolodny; Mitra Assadi; Larissa T Bilaniuk; Matthew J During; Jeremy S Francis; Andrew Freese; Olga Goldfarb; H Warren Goldman; Christopher G Janson
Long-term follow-up after gene therapy for canavan disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matthew During (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Katherine H Carruthers; Matthew J During; Alexander Muravlev; Chuansong Wang; Ergun Kocak
Fat grafting as a vehicle for the delivery of recombinant adenoassociated viral vectors to achieve gene modification of muscle flaps.
Annals of plastic surgery 2013;70(6):726-31.
2013: Peter Charbel Issa; Samantha R De Silva; Matthew J During; Mark W Hankins; Daniel M Lipinski; Alexandre Mouravlev; Mandeep S Singh; Qisheng You; Alun R Barnard; Robert E Maclaren
Assessment of Tropism and Effectiveness of New Primate-Derived Hybrid Recombinant AAV Serotypes in the Mouse and Primate Retina.
PloS one 2013;8(4):e60361.
2012: Paola Leone; S W J McPhee; R Jude Samulski; David Shera; Dah-Jyuu Wang; Deborah Young; Edwin H Kolodny; Mitra Assadi; Larissa T Bilaniuk; Matthew J During; Jeremy S Francis; Andrew Freese; Olga Goldfarb; H Warren Goldman; Christopher G Janson
Long-term follow-up after gene therapy for canavan disease.
Science translational medicine 2012;4(165):165ra163.
2011: John A Gray; Kenji Sakimura; Yun Shi; Hiroshi Usui; Matthew J During; Roger A Nicoll
Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo.
Neuron 2011;71(6):1085-101.
2011: Hsiao-Chun Cheng; Sang Ryong Kim; Tinmarla Frances Oo; Tatyana Kareva; Olga Yarygina; Margarita Rzhetskaya; Chuansong Wang; Matthew J During; Zsolt Talloczy; Keiji Tanaka; Masaaki Komatsu; Kazuto Kobayashi; Hideyuki Okano; Nikolai Kholodilov; Robert E Burke
Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31(6):2125-35.
2011: Wei Lu; John A Gray; Adam J Granger; Matthew J During; Roger A Nicoll
Potentiation of synaptic AMPA receptors induced by the deletion of NMDA receptors requires the GluA2 subunit.
Journal of neurophysiology 2011;105(2):923-8.
2010: F Noe; V Vaghi; C Balducci; H Fitzsimons; R Bland; Daniela Zardoni; G Sperk; M Carli; Matthew J During; Annamaria Vezzani
Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus.
Gene therapy 2010;17(5):643-52.
2009: Juliet Rashidian; Maxime W Rousseaux; Katerina Venderova; Dianbo Qu; Steven M Callaghan; Maryam Phillips; Ross J Bland; Matthew J During; Zixu Mao; ruth slack; Rousseaux Maxime
Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(40):12497-505.
2009: Patricia A Lawlor; Ross J Bland; Alexandre Mouravlev; Deborah Young; Matthew J During
Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(10):1692-702.
2009: Maggie L Kalev-Zylinska; Wymond Symes; Deborah Young; Matthew J During
Knockdown and overexpression of NR1 modulates NMDA receptor function.
Molecular and cellular neurosciences 2009;41(4):383-96.
2009: Vincent Ries; Hsiao-Chun Cheng; Amy Baohan; Tatyana Kareva; Tinmarla Frances Oo; Margarita Rzhetskaya; Ross J Bland; Matthew J During; Nikolai Kholodilov; Robert E Burke
Regulation of the postnatal development of dopamine neurons of the substantia nigra in vivo by Akt/protein kinase B.
Journal of neurochemistry 2009;110(1):23-33.
2009: Wei Lu; Yun Shi; Alexander C Jackson; Kirsten Bjorgan; Matthew J During; Rolf Sprengel; Peter H Seeburg; Roger A Nicoll
Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach.
Neuron 2009;62(2):254-68.
2009: Andreas T Sørensen; Litsa Nikitidou; Marco Ledri; En-Ju D Lin; Matthew J During; Kanter-Schlifke Irene; Merab Kokaia
Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP.
Experimental neurology 2009;215(2):328-33.
2009: Susan J Allison; Paul A Baldock; Ronaldo F Enriquez; EnJu Lin; Matthew J During; Edith M Gardiner; John A Eisman; Amanda Sainsbury; Herbert Herzog
Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009;24(2):294-304.
2009: Shu Lin; Yan-Chuan Shi; Ernie Yulyaningsih; Aygul Aljanova; Lei Zhang; Laurence Macia; Amy D Nguyen; En-Ju Lin; Matthew J During; Herbert Herzog; Amanda Sainsbury
Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice.
PloS one 2009;4(12):e8488.
2008: Andreas T Sørensen; Kanter-Schlifke Irene; En-Ju Lin; Matthew J During; Merab Kokaia
Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum.
Molecular and cellular neurosciences 2008;39(2):229-37.
2008: Francesco Noè; Allan-Hermann Pool; Jari Nissinen; Marco Gobbi; Ross Bland; Massimo Rizzi; Claudia Balducci; Francesco Ferraguti; Gunther Sperk; Matthew J During; Asla Pitkänen; Annamaria Vezzani
Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy.
Brain : a journal of neurology 2008;131(Pt 6):1506-15.
2008: Alisha E Jung; Helen L Fitzsimons; Ross J Bland; Matthew J During; Deborah Young
HSP70 and constitutively active HSF1 mediate protection against CDCrel-1-mediated toxicity.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(6):1048-55.
2008: Nicholas Franich; Helen L Fitzsimons; Dahna M Fong; Matthias Klugmann; Matthew J During; Deborah Young
AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(5):947-56.
2008: Hillel Adesnik; Guangnan Li; Matthew J During; Samuel J Pleasure; Roger A Nicoll
NMDA receptors inhibit synapse unsilencing during brain development.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(14):5597-602.
2008: Xiqun Chen; Margarita Rzhetskaya; Tatyana Kareva; Ross Bland; Matthew J During; A William Tank; Nikolai Kholodilov; Robert E Burke
Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(3):672-80.
2008: Andreas T Sørensen; Kanter-Schlifke Irene; Mirjana Carli; Claudia Balducci; Francesco Noe; Matthew J During; Annamaria Vezzani; Merab Kokaia
NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning.
Hippocampus 2008;18(6):564-74.
2007: Andrew Feigin; Michael Gordon Kaplitt; Chengke Tang; Tanya Lin; Paul Mattis; Vijay Dhawan; Matthew J During; David Eidelberg
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(49):19559-64.
2007: Hossein Aleyasin; Maxime W C Rousseaux; Maryam Phillips; Raymond H Kim; Ross J Bland; Steven M Callaghan; ruth slack; Matthew J During; Tak W Mak; Rousseaux Maxime
The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(47):18748-53.
2007: Heiko Johnen; Shu Lin; Tamara Kuffner; David A Brown; Vicky Wang-Wei Tsai; Asne R Bauskin; Liyun Wu; Greg J Pankhurst; Lele Jiang; Simon Junankar; Mark Hunter; W Douglas Fairlie; Nicola J Lee; Ronaldo F Enriquez; Paul A Baldock; Eva Corey; Fred S Apple; MaryAnn M Murakami; En-Ju Lin; Chuansong Wang; Matthew J During; Amanda Sainsbury; Herbert Herzog; Samuel N Breit
Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1.
Nature medicine 2007;13(11):1333-40.
2007: Birgitte Tiesjema; Susanne E La Fleur; Mieneke C M Luijendijk; Maike A D Brans; En-Ju Lin; Matthew J During; Roger A H Adan
Viral mediated neuropeptide Y expression in the rat paraventricular nucleus results in obesity.
Obesity (Silver Spring, Md.) 2007;15(10):2424-35.
2007: Maggie L Kalev-Zylinska; Matthew J During
Paradoxical facilitatory effect of low-dose alcohol consumption on memory mediated by NMDA receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(39):10456-67.
2007: Jonathan Brouillette; Deborah Young; Matthew J During; Rémi Quirion
Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABA(B) receptors in scopolamine-induced amnesia.
Journal of neurochemistry 2007;102(6):1978-89.
2007: Paul A Baldock; Susan J Allison; Pernilla Lundberg; Nicola J Lee; Katy Slack; En-Ju Lin; Ronaldo F Enriquez; Michelle M McDonald; Lei Zhang; Matthew J During; David G Little; John A Eisman; Edith M Gardiner; Ernie Yulyaningsih; Shu Lin; Amanda Sainsbury; Herbert Herzog
Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis.
The Journal of biological chemistry 2007;282(26):19092-102.
2007: Michael Gordon Kaplitt; Andrew Feigin; Chengke Tang; Helen L Fitzsimons; Paul Mattis; Patricia A Lawlor; Ross J Bland; Deborah Young; Kristin Strybing; David Eidelberg; Matthew J During
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.
Lancet 2007;369(9579):2097-105.
2007: Shu Lin; En-Ju Lin; Dana Boey; Nicola J Lee; Katy Slack; Matthew J During; Amanda Sainsbury; Herbert Herzog
Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways.
Endocrinology 2007;148(5):2056-65.
2007: Marina E Emborg; Maren Carbon; James E Holden; Matthew J During; Yilong Ma; Chengke Tang; Jeffrey Moirano; Helen L Fitzsimons; Ben Roitberg; Eray Tuccar; Andrew Roberts; Michael Gordon Kaplitt; David Eidelberg
Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2007;27(3):501-9.
2007: Francesco Noe'; Jari Nissinen; Asla Pitkänen; Marco Gobbi; Günther Sperk; Matthew J During; Annamaria Vezzani
Gene therapy in epilepsy: the focus on NPY.
Peptides 2007;28(2):377-83.
2007: Alexandre Mouravlev; Deborah Young; Matthew J During
Phosphorylation-dependent degradation of transgenic CREB protein initiated by heterodimerization.
Brain research 2007;1130(1):31-7.
2007: Patricia A Lawlor; Ross J Bland; Pritam Das; Robert W Price; Vallie M Holloway; Lisa A Smithson; Bridget L Dicker; Matthew J During; Deborah Young; todd golde
Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levels.
Molecular neurodegeneration 2007;2():11.
2006: Vincent Ries; Claire Henchcliffe; Tatyana Kareva; Margarita Rzhetskaya; Ross Bland; Matthew J During; Nikolai Kholodilov; Robert E Burke
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(49):18757-62.
2006: En-Ju Lin; Amanda Sainsbury; Nicola J Lee; Dana Boey; Michelle Couzens; Ronaldo F Enriquez; Katy Slack; Ross Bland; Matthew J During; Herbert Herzog
Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.
Endocrinology 2006;147(11):5094-101.
2006: Susan J Allison; Paul A Baldock; Amanda Sainsbury; Ronaldo F Enriquez; Nicola J Lee; En-Ju Lin; Matthias Klugmann; Matthias Klugman; Matthew J During; John A Eisman; Mei Li; Lydia C Pan; Herbert Herzog; Edith M Gardiner
Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice.
The Journal of biological chemistry 2006;281(33):23436-44.
2006: Krisztina Monory; Federico Massa; Michaela Egertová; Matthias Eder; Heike Blaudzun; Ruth E Westenbroek; Wolfgang Kelsch; Wolfgang Jacob; Rudolf Marsch; Marc Ekker; Jason Long; John L Rubenstein; Sandra Goebbels; Klaus-Armin Nave; Matthew J During; Matthias Klugmann; Barbara Wölfel; Hans-Ulrich Dodt; Walter Zieglgänsberger; Carsten T Wotjak; Ken Mackie; Maurice R Elphick; Giovanni Marsicano; Beat Lutz
The endocannabinoid system controls key epileptogenic circuits in the hippocampus.
Neuron 2006;51(4):455-66.
2006: Anke Tappe; Matthias Klugmann; Ceng Luo; David Hirlinger; Nitin Agarwal; Justus Benrath; Markus U Ehrengruber; Matthew J During; Rohini Kuner
Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain.
Nature medicine 2006;12(6):677-81.
2006: En-Ju Lin; Deborah Young; Kristin Baer; Herbert Herzog; Matthew J During
Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
Epilepsia 2006;47(4):773-80.
2006: Karen K Szumlinski; Kenneth E Abernathy; Erik Oleson; Matthias Klugmann; Kevin D Lominac; Dao-Yao He; Dorit Ron; Matthew J During; Peter W Kalivas
Homer isoforms differentially regulate cocaine-induced neuroplasticity.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(4):768-77.
2006: Alexandre Mouravlev; Jane Dunning; Deborah Young; Matthew J During
Somatic gene transfer of cAMP response element-binding protein attenuates memory impairment in aging rats.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(12):4705-10.
2006: Valerie G Olson; Carrie L Heusner; Ross J Bland; Matthew J During; David Weinshenker; Richard D Palmiter
Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward.
Science (New York, N.Y.) 2006;311(5763):1017-20.
2006: Siobhan Robinson; Bethany N Sotak; Matthew J During; Richard D Palmiter
Local dopamine production in the dorsal striatum restores goal-directed behavior in dopamine-deficient mice.
Behavioral neuroscience 2006;120(1):196-200.
2006: Matthew J During; Lei Cao
VEGF, a mediator of the effect of experience on hippocampal neurogenesis.
Current Alzheimer research 2006;3(1):29-33.
2006: Matthias Klugmann; Claudia B Leichtlein; C Wymond Symes; Bettina C Klaussner; Andrew I Brooks; Deborah Young; Matthew J During
A novel role of circadian transcription factor DBP in hippocampal plasticity.
Molecular and cellular neurosciences 2006;31(2):303-14.
2005: Kevin D Lominac; Erik Oleson; Matthew Pava; Matthias Klugmann; Martin K Schwarz; Peter H Seeburg; Matthew J During; Paul F Worley; Peter W Kalivas; Karen K Szumlinski
Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(50):11586-94.
2005: Paul A Baldock; Amanda Sainsbury; Susan Allison; En-Ju Lin; Michelle Couzens; Dana Boey; Ronaldo F Enriquez; Matthew J During; Herbert Herzog; Edith M Gardiner
Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(10):1851-7.
2005: Juliet Rashidian; Grace Iyirhiaro; Hossein Aleyasin; Mario Rios; Inez Vincent; Steven M Callaghan; Ross J Bland; ruth slack; Matthew J During; David Park
Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(39):14080-5.
2005: Ruian Xu; Mehdi Rahimi; Hsu Ma; Peter Fung; Chunqi Chang; Sue Xu; Matthew J During
Stability of infectious recombinant adeno-associated viral vector in gene delivery.
Medical science monitor : international medical journal of experimental and clinical research 2005;11(9):BR305-8.
2005: Karen K Szumlinski; Kevin D Lominac; Erik Oleson; Jennifer K Walker; Ashley Mason; Marlin H Dehoff; Matthias Klugmann; Matthias Klugman; Stephanie Cagle; Kristine Welt; Matthew J During; Paul F Worley; Lawrence D Middaugh; Peter W Kalivas
Homer2 is necessary for EtOH-induced neuroplasticity.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(30):7054-61.
2005: Matthias Klugmann; Claudia B Leichtlein; C Wymond Symes; Tadao Serikawa; Deborah Young; Matthew J During
Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(5):745-53.
2005: Matthias Klugmann; C Wymond Symes; Claudia B Leichtlein; Bettina K Klaussner; Jane Dunning; Dahna Fong; Deborah Young; Matthew J During
AAV-mediated hippocampal expression of short and long Homer 1 proteins differentially affect cognition and seizure activity in adult rats.
Molecular and cellular neurosciences 2005;28(2):347-60.
2004: James S Harrop; David Poulsen; Weidong Xiao; Andrew Freese; Matthew J During
Effect of altering titer, serotype, and promoter in recombinant adenoassociate virus gene therapy expression of spinal cord neurons and astrocytes.
Spine 2004;29(24):2787-92.
2004: Francesco Trapasso; Sai Yendamuri; Kristoffel R Dumon; Rodolfo Iuliano; Rossano Cesari; Byron Feig; Robin Seto; Luisa Infante; Hideshi Ishii; Aldo Vecchione; Matthew J During; Carlo M Croce; Alfredo Fusco
Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo.
Carcinogenesis 2004;25(11):2107-14.
2004: Claire Matson Cannon; Luna Abdallah; Laurence H Tecott; Matthew J During; Richard D Palmiter
Dysregulation of striatal dopamine signaling by amphetamine inhibits feeding by hungry mice.
Neuron 2004;44(3):509-20.
2004: Thomas S Hnasko; Mark S Szczypka; William Alaynick; Matthew J During; Richard D Palmiter
A role for dopamine in feeding responses produced by orexigenic agents.
Brain research 2004;1023(2):309-18.
2004: Karen K Szumlinski; Marlin H Dehoff; Shin H Kang; Kelly A Frys; Kevin D Lominac; Matthias Klugmann; Jason Rohrer; William C Griffin; Shigenobu Toda; Nicholas Champtiaux; Thomas Berry; Jian Cheng Tu; Stephanie E Shealy; Matthew J During; Lawrence D Middaugh; Paul F Worley; Peter W Kalivas
Homer proteins regulate sensitivity to cocaine.
Neuron 2004;43(3):401-13.
2004: Lei Cao; Xiangyang Jiao; David S Zuzga; Yuhong Liu; Dahna M Fong; Deborah Young; Matthew J During
VEGF links hippocampal activity with neurogenesis, learning and memory.
Nature genetics 2004;36(8):827-35.
2004: Jeremy S Francis; Michael Dragunow; Matthew J During
Over expression of ATF-3 protects rat hippocampal neurons from in vivo injection of kainic acid.
Brain research. Molecular brain research 2004;124(2):199-203.
2004: Adrian P Kells; Dahna M Fong; Michael Dragunow; Matthew J During; Deborah Young; Bronwen Connor
AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(5):682-8.
2004: Aaron J Noordmans; D K Song; C J Noordmans; Mary E Garrity-Moses; Matthew J During; Helen L Fitzsimons; Michael J Imperiale; Nicholas M Boulis
Adeno-associated viral glutamate decarboxylase expression in the lateral nucleus of the rat hypothalamus reduces feeding behavior.
Gene therapy 2004;11(9):797-804.
2004: William A Banks; Matthew J During; Michael L Niehoff
Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration.
The Journal of pharmacology and experimental therapeutics 2004;309(2):469-75.
2004: Cristina Richichi; En-Ju Lin; Daniela Stefanin; Daniele Colella; Teresa Ravizza; Giuliano Grignaschi; Pietro Veglianese; Günther Sperk; Matthew J During; Annamaria Vezzani
Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(12):3051-9.
2004: Patricia A Lawlor; Matthew J During
Gene therapy for Parkinson's disease.
Expert reviews in molecular medicine 2004;6(5):1-18.
2004: Deborah Young; Matthew J During
Using the immune system to target epilepsy.
Advances in experimental medicine and biology 2004;548():134-44.
2003: Andree G Pearson; Carol W Gray; John F Pearson; Jeffrey M Greenwood; Matthew J During; Michael Dragunow
ATF3 enhances c-Jun-mediated neurite sprouting.
Brain research. Molecular brain research 2003;120(1):38-45.
2003: Nicholas M Boulis; Aaron J Noordmans; Debbie K Song; Michael J Imperiale; Adam Rubin; Paola Leone; Matthew J During; Eva L Feldman
Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery.
Neurobiology of disease 2003;14(3):535-41.
2003: Matthew J During
Gene therapy in Parkinson's disease.
Expert review of neurotherapeutics 2003;3(6):729-32.
2003: Colin N Haile; Matthew J During; Peter Jatlow; Thomas R Kosten; Therese A Kosten
Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats.
Biological psychiatry 2003;54(9):915-21.
2003: Matthias Klugmann; C Wymond Symes; Bettina K Klaussner; Claudia B Leichtlein; Tadao Serikawa; Deborah Young; Matthew J During
Identification and distribution of aspartoacylase in the postnatal rat brain.
Neuroreport 2003;14(14):1837-40.
2003: Jane Dunning; Matthew J During
Molecular mechanisms of learning and memory.
Expert reviews in molecular medicine 2003;5(25):1-11.
2003: En-Ju Lin; Cristina Richichi; Deborah Young; Kristin Baer; Annamaria Vezzani; Matthew J During
Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development.
The European journal of neuroscience 2003;18(7):2087-92.
2003: Hideshi Ishii; nicola zanesi; Aldo Vecchione; Francesco Trapasso; Sai Yendamuri; Manuela Sarti; Raffaele Baffa; Matthew J During; Kay Huebner; Louise Y Y Fong; Carlo M Croce
Regression of upper gastric cancer in mice by FHIT gene delivery.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(12):1768-70.
2003: Matthew J During; Lei Cao; David S Zuzga; Jeremy S Francis; Helen L Fitzsimons; Xiangyang Jiao; Ross J Bland; Matthias Klugmann; William A Banks; Daniel J Drucker; Colin N Haile
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection.
Nature medicine 2003;9(9):1173-9.
2003: Carrie L Heusner; Thomas S Hnasko; Mark S Szczypka; Yuhong Liu; Matthew J During; Richard D Palmiter
Viral restoration of dopamine to the nucleus accumbens is sufficient to induce a locomotor response to amphetamine.
Brain research 2003;980(2):266-74.
2003: Jodi L McBride; Matthew J During; Joanne Wuu; Er-Yun Chen; Sue Leurgans; Jeffrey Kordower
Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.
Experimental neurology 2003;181(2):213-23.
2003: Suzanne J Reid; Mark I Rees; Willeke van Roon-Mom; A Lesley Jones; Marcy E MacDonald; Greg Sutherland; Matthew J During; Richard L M Faull; Michael J Owen; Michael Dragunow; Russell G Snell
Molecular investigation of TBP allele length: a SCA17 cellular model and population study.
Neurobiology of disease 2003;13(1):37-45.
2003: Hsu Ma; Ruian Xu; Henrich Cheng; Huai-Sheng Kuo; Matthew J During; Rong-Hwang Fang
Gene transfer into human keloid tissue with adeno-associated virus vector.
The Journal of trauma 2003;54(3):569-73.
2003: Kristin Baer; Henry J Waldvogel; Matthew J During; Russell G Snell; Richard L M Faull; Mark I Rees
Association of gephyrin and glycine receptors in the human brainstem and spinal cord: an immunohistochemical analysis.
Neuroscience 2003;122(3):773-84.
2003: Henry J Waldvogel; Kristin Baer; Russell G Snell; Matthew J During; Richard L M Faull; Mark I Rees
Distribution of gephyrin in the human brain: an immunohistochemical analysis.
Neuroscience 2003;116(1):145-56.
2003: Matthew J During; Deborah Young; Kristin Baer; Patricia Lawlor; Matthias Klugmann
Development and optimization of adeno-associated virus vector transfer into the central nervous system.
Methods in molecular medicine 2003;76():221-36.
2002: Jia Luo; Michael Gordon Kaplitt; Helen L Fitzsimons; David S Zuzga; Yuhong Liu; Michael L Oshinsky; Matthew J During
Subthalamic GAD gene therapy in a Parkinson's disease rat model.
Science (New York, N.Y.) 2002;298(5592):425-9.
2002: Helen L Fitzsimons; Ross J Bland; Matthew J During
Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain.
Methods (San Diego, Calif.) 2002;28(2):227-36.
2002: L Cao; Matthew J During; W Xiao
Replication competent helper functions for recombinant AAV vector generation.
Gene therapy 2002;9(18):1199-206.
2002: Mihail Y Mastakov; Kristin Baer; C Wymond Symes; Claudia B Leichtlein; robert kotin; Matthew J During
Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain.
Journal of virology 2002;76(16):8446-54.
2002: Theresa C Peterson; Marc Rodney Peterson; Harold A Robertson; Matthew J During; Michael Dragunow
Selective down-regulation of c-jun gene expression by pentoxifylline and c-jun antisense interrupts platelet-derived growth factor signaling: pentoxifylline inhibits phosphorylation of c-Jun on serine 73.
Molecular pharmacology 2002;61(6):1476-88.
2002: Mihail Y Mastakov; Kristin Baer; robert kotin; Matthew J During
Recombinant adeno-associated virus serotypes 2- and 5-mediated gene transfer in the mammalian brain: quantitative analysis of heparin co-infusion.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(4):371-80.
2002: Walid Abi-Saab; David G Maggs; Tim Jones; Ralph Jacob; Vinod Srihari; James Thompson; David Kerr; Paola Leone; John H Krystal; Dennis D Spencer; Matthew J During; Robert S Sherwin
Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2002;22(3):271-9.
2002: David Poulsen; James S Harrop; Matthew J During
Gene therapy for spinal cord injury and disease.
The journal of spinal cord medicine 2002;25(1):2-9.
2001: Christopher G Janson; T M Ramesh; Matthew J During; Paola Leone; J Heywood
Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis.
Journal of hematotherapy & stem cell research 2001;10(6):913-5.
2001: Christopher G Janson; S W J McPhee; Paola Leone; Andrew Freese; Matthew J During
Viral-based gene transfer to the mammalian CNS for functional genomic studies.
Trends in neurosciences 2001;24(12):706-12.
2001: Helen L Fitzsimons; J M Mckenzie; Matthew J During
Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain.
Gene therapy 2001;8(22):1675-81.
2001: Christopher G Janson; Matthew J During
Viral vectors as part of an integrated functional genomics program.
Genomics 2001;78(1-2):3-6.
2001: Ruian Xu; Christopher G Janson; Mihail Y Mastakov; Patricia A Lawlor; Deborah Young; Alexandre Mouravlev; Helen L Fitzsimons; Kai-Luk Choi; H Ma; Michael Dragunow; Paola Leone; Q Chen; Bridget L Dicker; Matthew J During
Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes.
Gene therapy 2001;8(17):1323-32.
2001: Kristoffel R Dumon; Hideshi Ishii; Aldo Vecchione; Francesco Trapasso; Gustavo Baldassarre; F Chakrani; Teresa Druck; E F Rosato; Noel N Williams; Raffaele Baffa; Matthew J During; Kay Huebner; Carlo M Croce
Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer.
Cancer research 2001;61(12):4827-36.
2001: Kristoffel R Dumon; Hideshi Ishii; Louise Y Y Fong; nicola zanesi; Vincenzo Fidanza; Rita Mancini; Aldo Vecchione; Raffaele Baffa; Francesco Trapasso; Matthew J During; Kay Huebner; Carlo M Croce
FHIT gene therapy prevents tumor development in Fhit-deficient mice.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(6):3346-51.
2001: Mihail Y Mastakov; Kristin Baer; Ruian Xu; Helen L Fitzsimons; Matthew J During
Combined injection of rAAV with mannitol enhances gene expression in the rat brain.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(2):225-32.
2000: L Cao; Y Liu; Matthew J During; W Xiao
High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids.
Journal of virology 2000;74(24):11456-63.
2000: Michael Dragunow; Ruian Xu; M Walton; AM Woodgate; Patricia A Lawlor; Geraldine MacGibbon; Deborah Young; Hannah M Gibbons; Janusz Lipski; A Muravlev; A Pearson; Matthew J During
c-Jun promotes neurite outgrowth and survival in PC12 cells.
Brain research. Molecular brain research 2000;83(1-2):20-33.
2000: A E Telfeian; Howard Federoff; P Leone; Matthew J During; A Williamson
Overexpression of GluR6 in rat hippocampus produces seizures and spontaneous nonsynaptic bursting in vitro.
Neurobiology of disease 2000;7(4):362-74.
2000: Paola Leone; Christopher G Janson; Larissa T Bilaniuk; Z Wang; F Sorgi; L Huang; R Matalon; R Kaul; Z Zeng; Andrew Freese; S W J McPhee; E Mee; Matthew J During; L Bilianuk
Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease.
Annals of neurology 2000;48(1):27-38.
2000: P Leone; S W J McPhee; Christopher G Janson; BL Davidson; Andrew Freese; Matthew J During
Multi-site partitioned delivery of human tyrosine hydroxylase gene with phenotypic recovery in Parkinsonian rats.
Neuroreport 2000;11(6):1145-51.
2000: Matthew J During; C Wymond Symes; Patricia A Lawlor; J Lin; Jane Dunning; Helen L Fitzsimons; David Poulsen; Paola Leone; Ruian Xu; Bridget L Dicker; Janusz Lipski; Deborah Young
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy.
Science (New York, N.Y.) 2000;287(5457):1453-60.
1999: M Walton; AM Woodgate; A Muravlev; Ruian Xu; Matthew J During; Michael Dragunow
CREB phosphorylation promotes nerve cell survival.
Journal of neurochemistry 1999;73(5):1836-42.
1999: Paola Leone; Christopher G Janson; S J McPhee; Matthew J During
Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease.
Current opinion in molecular therapeutics 1999;1(4):487-92.
1999: Matthew J During; Christopher G Janson
PNAs breach the blood-brain barrier?
Nature biotechnology 1999;17(8):753-4.
1999: Deborah Young; Patricia A Lawlor; Paola Leone; Michael Dragunow; Matthew J During
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective.
Nature medicine 1999;5(4):448-53.
1998: Matthew J During; Ruian Xu; Deborah Young; Michael Gordon Kaplitt; Robert S Sherwin; Paola Leone
Peroral gene therapy of lactose intolerance using an adeno-associated virus vector.
Nature medicine 1998;4(10):1131-5.
1998: Matthew J During; R Jude Samulski; John D Elsworth; Michael Gordon Kaplitt; Paola Leone; Xiao Xiao; J Li; Andrew Freese; Jane R Taylor; Robert H Roth; John R Sladek; Karen L O'Malley; D Eugene Redmond
In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector.
Gene therapy 1998;5(6):820-7.
1998: S Song; Y Wang; S Y Bak; Matthew J During; J Bryan; O Ashe; D B Ullrey; L E Trask; F D Grant; Karen L O'Malley; Heimo Riedel; David S Goldstein; Kim A Neve; Gerald J LaHoste; John F Marshall; J W Haycock; Rachael L Neve; Alfred I Geller
Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(11):4119-32.
1997: W M O'Connor; BL Davidson; Michael Gordon Kaplitt; MV Abbey; Matthew J During; Paola Leone; David Langer; Michael J O'Connor; Andrew Freese
Adenovirus vector-mediated gene transfer into human epileptogenic brain slices: prospects for gene therapy in epilepsy.
Experimental neurology 1997;148(1):167-78.
1997: Andrew Freese; Michael Gordon Kaplitt; W M O'Connor; MV Abbey; David Langer; Paola Leone; Michael J O'Connor; Matthew J During
Direct gene transfer into human epileptogenic hippocampal tissue with an adeno-associated virus vector: implications for a gene therapy approach to epilepsy.
Epilepsia 1997;38(7):759-66.
1996: Andrew Freese; Matthew B Stern; Michael Gordon Kaplitt; W M O'Connor; MV Abbey; Michael J O'Connor; Matthew J During
Prospects for gene therapy in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1996;11(5):469-88.
1996: Andrew Freese; Matthew J During; Beverly L Davidson; T A Gennarelli; Michael Gordon Kaplitt; Eugene S Flamm; Peter J Snyder
Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release.
The Journal of clinical endocrinology and metabolism 1996;81(6):2401-4.
1996: W K Tan; Christopher E Williams; Matthew J During; C E Mallard; Mark I Gunning; Alistair J Gunn; Peter D Gluckman
Accumulation of cytotoxins during the development of seizures and edema after hypoxic-ischemic injury in late gestation fetal sheep.
Pediatric research 1996;39(5):791-7.
1995: Matthew J During; K M Ryder; D D Spencer
Hippocampal GABA transporter function in temporal-lobe epilepsy.
Nature 1995;376(6536):174-7.
1995: David G Maggs; Ralph Jacob; F Rife; R Lange; P Leone; Matthew J During; William V Tamborlane; Robert S Sherwin
Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle.
The Journal of clinical investigation 1995;96(1):370-7.
1995: Matthew J During; P Leone; K E Davis; D Kerr; Robert S Sherwin
Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels.
The Journal of clinical investigation 1995;95(5):2403-8.
1995: L M Boulanger; Paul J Lombroso; A Raghunathan; Matthew J During; Petra Wahle; Janice R Naegele
Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1995;15(2):1532-44.
1995: Walter Borg; Robert S Sherwin; Matthew J During; Monica A Borg; Gerald I Shulman
Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release.
Diabetes 1995;44(2):180-4.
1995: Alfred I Geller; Matthew J During; Young J Oh; Andrew Freese; Karen L O'Malley
An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells.
Journal of neurochemistry 1995;64(2):487-96.
1995: Matthew J During; Paola Leone
Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
Clinical neuroscience (New York, N.Y.) 1995;3(5):292-300.
1994: Matthew J During; Janice R Naegele; Karen L O'Malley; Alfred I Geller
Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase.
Science (New York, N.Y.) 1994;266(5189):1399-403.
1994: Michael Gordon Kaplitt; Paola Leone; R Jude Samulski; Xiao Xiao; Donald Pfaff; Karen L O'Malley; Matthew J During
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.
Nature genetics 1994;8(2):148-54.
1994: Richard D Scheyer; Matthew J During; Dennis D Spencer; Joyce A Cramer; Richard H Mattson
Measurement of carbamazepine and carbamazepine epoxide in the human brain using in vivo microdialysis.
Neurology 1994;44(8):1469-72.
1994: Richard D Scheyer; Matthew J During; J M Hochholzer; Dennis D Spencer; Joyce A Cramer; Richard H Mattson
Phenytoin concentrations in the human brain: an in vivo microdialysis study.
Epilepsy research 1994;18(3):227-32.
1994: Matthew J During; I Fried; P Leone; A Katz; Dennis D Spencer
Direct measurement of extracellular lactate in the human hippocampus during spontaneous seizures.
Journal of neurochemistry 1994;62(6):2356-61.
1994: Walter Borg; Matthew J During; Robert S Sherwin; Monica A Borg; Michael Brines; Gerald I Shulman
Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.
The Journal of clinical investigation 1994;93(4):1677-82.
1993: S Ochi; J Y Lim; M N Rand; Matthew J During; K Sakatani; Jeffery D Kocsis
Transient presence of GABA in astrocytes of the developing optic nerve.
Glia 1993;9(3):188-98.
1993: D Kerr; Robert S Sherwin; F Pavalkis; Pierre Fayad; L Sikorski; F Rife; William V Tamborlane; Matthew J During
Effect of caffeine on the recognition of and responses to hypoglycemia in humans.
Annals of internal medicine 1993;119(8):799-804.
1993: Alfred I Geller; Matthew J During; J W Haycock; Andrew Freese; Rachael L Neve
Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(16):7603-7.
1993: Victor Perry; R S Young; W J Aquila; Matthew J During
Effect of experimental Escherichia coli meningitis on concentrations of excitatory and inhibitory amino acids in the rabbit brain: in vivo microdialysis study.
Pediatric research 1993;34(2):187-91.
1993: E Sybirska; John P Seibyl; J Douglas Bremner; Ronald M Baldwin; Mohammed S Al-Tikriti; Charles W Bradberry; Robert T Malison; Yolanda Zea-Ponce; Sami S Zoghbi; Matthew J During
[123I]iomazenil SPECT imaging demonstrates significant benzodiazepine receptor reserve in human and nonhuman primate brain.
Neuropharmacology 1993;32(7):671-80.
1993: Matthew J During; Dennis D Spencer
Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain.
Lancet 1993;341(8861):1607-10.
1993: A Thomas-Reetz; Johannes Hell; Matthew J During; Christiane Walch-Solimena; Reinhard Jahn; Pietro De Camilli
A gamma-aminobutyric acid transporter driven by a proton pump is present in synaptic-like microvesicles of pancreatic beta cells.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(11):5317-21.
1993: R S Young; Matthew J During; D F Donnelly; W J Aquila; Victor Perry; Gabriel G Haddad
Effect of anoxia on excitatory amino acids in brain slices of rats and turtles: in vitro microdialysis.
The American journal of physiology 1993;264(4 Pt 2):R716-9.
1992: Matthew J During; Dennis D Spencer
Adenosine: a potential mediator of seizure arrest and postictal refractoriness.
Annals of neurology 1992;32(5):618-24.
1992: R S Young; Matthew J During; W J Aquila; D Tendler; E Ley
Hypoxia increases extracellular concentrations of excitatory and inhibitory neurotransmitters in subsequently induced seizure: in vivo microdialysis study in the rabbit.
Experimental neurology 1992;117(2):204-9.
1992: Matthew J During; J S Craig; Theresa Dea Hernandez; george anderson; DW Gallager
Effect of amygdala kindling on the in vivo release of GABA and 5-HT in the dorsal raphe nucleus in freely moving rats.
Brain research 1992;584(1-2):36-44.
1992: Matthew J During; A J Bean; Robert H Roth
Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex.
Neuroscience letters 1992;140(1):129-33.
1992: Matthew J During; Andrew Freese; Ariel Deutch; P G Kibat; Bernhard A Sabel; Robert Langer; Robert H Roth
Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomes.
Experimental neurology 1992;115(2):193-9.
1991: Alfred I Geller; Matthew J During; Rachael L Neve
Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors.
Trends in neurosciences 1991;14(10):428-32.
1991: Matthew J During; M P Heyes; Andrew Freese; K J Swartz; Wayne R Matson; Sanford Markey; J B Martin; Robert H Roth
Indolic and kynurenine pathway metabolites of tryptophan in rat brain: effect of precursor availability on in vivo release.
Advances in experimental medicine and biology 1991;294():535-9.
1991: Rachael L Neve; KJ Ivins; Larry I Benowitz; Matthew J During; Alfred I Geller
Molecular analysis of the function of the neuronal growth-associated protein GAP-43 by genetic intervention.
Molecular neurobiology 1991;5(2-4):131-41.
1990: K J Swartz; Matthew J During; Andrew Freese; M Flint Beal
Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1990;10(9):2965-73.
1990: Andrew Freese; K J Swartz; Matthew J During; J B Martin
Kynurenine metabolites of tryptophan: implications for neurologic diseases.
Neurology 1990;40(4):691-5.
1990: A J Bean; Matthew J During; Robert H Roth
Effects of dopamine autoreceptor stimulation on the release of colocalized transmitters: in vivo release of dopamine and neurotensin from rat prefrontal cortex.
Neuroscience letters 1990;108(1-2):143-8.
1989: A J Bean; Matthew J During; Ariel Deutch; Robert H Roth
Effects of dopamine depletion on striatal neurotensin: biochemical and immunohistochemical studies.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1989;9(12):4430-8.
1989: A J Bean; Matthew J During; Robert H Roth
Stimulation-induced release of coexistent transmitters in the prefrontal cortex: an in vivo microdialysis study of dopamine and neurotensin release.
Journal of neurochemistry 1989;53(2):655-7.
1989: Matthew J During; Andrew Freese; M P Heyes; K J Swartz; Sanford Markey; Robert H Roth; J B Martin
Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid. Effect of tryptophan loading.
FEBS letters 1989;247(2):438-44.
1989: Matthew J During; Andrew Freese; Bernhard A Sabel; W M Saltzman; Ariel Deutch; Robert H Roth; Robert Langer
Controlled release of dopamine from a polymeric brain implant: in vivo characterization.
Annals of neurology 1989;25(4):351-6.
1989: Matthew J During; M P Heyes; Andrew Freese; Sanford Markey; J B Martin; Robert H Roth
Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systemic L-tryptophan loading.
Brain research 1989;476(2):384-7.